Single compartment drug delivery
Drug design is built on the concept that key molecular targets of disease are isolated in the diseased tissue. Systemic drug administration would be sufficient for targeting in such a case. It is, however, common for enzymes or receptors that are integral to disease to be structurally similar or ide...
Main Authors: | Cima, Michael J., Daniel, Karen, Mantzavinou, Aikaterini, Ong, Qunya, Sy, Jay C., Santini, John, Blankschtein, Daniel, Tanenbaum, Laura Melanie, Lee, Heejin, 1976-, Spencer, Kevin C, Schoellhammer, Carl Magnus, Langer, Robert S |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/101146 https://orcid.org/0000-0003-2379-6139 https://orcid.org/0000-0001-6694-6761 https://orcid.org/0000-0002-7963-8706 https://orcid.org/0000-0001-8586-6900 https://orcid.org/0000-0002-7836-415X https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
by: Schoellhammer, Carl Magnus, et al.
Published: (2014) -
Ultrasound-enhanced transdermal delivery: recent advances and future challenges
by: Blankschtein, Daniel, et al.
Published: (2016) -
Sustained-release implants for intraperitoneal cisplatin delivery
by: Mantzavinou, Aikaterini
Published: (2019) -
Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs
by: Schoellhammer, Carl Magnus, et al.
Published: (2017) -
Use of physical enhancers for gastrointestinal and transdermal drug delivery
by: Schoellhammer, Carl M. (Carl Magnus)
Published: (2015)